Protease-activated receptors, apoptosis and tumor growth

Pathophysiology of Haemostasis and Thrombosis

Volumn 36, Issue 3-4, 2008, Pages 137-147

  Borensztajn, Keren S ^a   Spek, C Arnold ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Blood coagulation and cancer; Coagulation factors; Protease activated receptors; Tumor growth

Indexed keywords

PROTEINASE ACTIVATED RECEPTOR; BLOOD CLOTTING FACTOR; CASPASE; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RHODOPSIN; THROMBOPLASTIN; TUMOR PROTEIN;

APOPTOSIS; BLOOD CLOTTING; CELL SURVIVAL; DISEASE ASSOCIATION; ENZYME ACTIVATION; HUMAN; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CELL DIVISION; CELL TRANSFORMATION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG POTENTIATION; GENETICS; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; THROMBOPHILIA;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BLOOD COAGULATION FACTORS; CASPASES; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CONSERVED SEQUENCE; ENZYME ACTIVATION; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MICE; MICE, KNOCKOUT; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, PROTEINASE-ACTIVATED; RHODOPSIN; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; THROMBOPHILIA; THROMBOPLASTIN;

EID: 61449251834     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000175152     Document Type: Review

References (112)

1. Furie B, Furie BC: The molecular basis of blood coagulation. Cell 1988;53:505-518.
2. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem 1995;270: 4650-4660.
3. Nystedt S, et al: Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur J Biochem 1995;232: 84-89.
4. Nystedt S, et al: Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA 1994;91 : 9208-9212.
5. Nystedt S, et al: The mouse proteinase-acti-vated receptor-2 cDNA and gene. Molecular cloning and functional expression. J Biol Chem 1995;270:5950-5955.
6. Chen J, et al: Tissue factor- a receptor involved in the control of cellular properties, including angiogenesis. Thromb Haemost 2001;86: 33 4-3 45.
7. Chen LB, Buchanan JM: Mitogenic activity of blood components. I. Thrombin and pro-t hrombin. Proc Nat l Acad Sci USA 1975;72: 131-135.
8. Zetter BR, Chen LB, Buchanan JM: Effects of protease treatment on growth, morphology, adhesion, and cell surface proteins of secondary chick embryo fibroblasts. Cell 1976;7:407-412.
9. Coughlin SR: Thrombin signalling and pro-tease-activated receptors. Nature 2000;407: 258-264.
10. Barry GD, Le GT, Fairlie DP: Agonists and antagonists of protease-activated receptors. Curr Med Chem 2006;13: 243-265.
11. Macfarlane SR, et al: Proteinase-activated receptors. Pharmacol Rev 2001;53: 245-282.
12. Ossovskaya VS, Bunnett NW: Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004;84: 579- 621.
13. O'Brien PJ, et al: Protease activated receptors: theme and variations. Oncogene 2001;20:1570-1581.
14. Buller HR, et al: Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 2007;5(suppl 1): 2 4 6-254 .
15. Kakkar AK: An expanding role for anti-thrombotic therapy in cancer patients. Cancer Treat Rev 2003;29(suppl 2):23-26.
16. Kakkar AK: Low-molecular-weight heparins: beyond thrombosis in the management of the cancer patient. Semin Thromb Hemost 2003;29(suppl 1):13-15.
17. Klerk CP, et al: Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to factor V Leiden mutation. J Cell Mol Med 2007;11:561-568.
18. Zacharski LR, et al: Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thromb Haemost 1995;73:793-797.
19. Nierodzik ML, Karpatkin S: Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 2006;10:355-362.
20. Yang L, et al: Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res 2003;63:6815-6824.
21. O'Connor L, et al: Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998;17:384-395.
22. Bouillet P, et al: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreac-tive thy moc y tes. Nature 20 02;415: 922-926.
23. Whitfield J, et al: Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochon-drial cytochrome c release. Neuron 2001;29: 629-643.
24. Chen LB, Teng NN, Buchanan JM: Mitogenicity of thrombin and surface alterations on mouse splenocytes. Exp Cell Res 1976;101: 41-46.
25. Vu TK, et al: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991;6 4: 10 5 7-10 6 8 .
26. Connolly AJ, et al: Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996;381:516-519.
27. Ishihara H, et al: Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997;386:502-506.
28. Kahn ML, et al: A dual thrombin receptor system for platelet activation. Nature 1998;394:690-694.
29. Xu WF, et al: Cloning and characterization of human protease-activated receptor 4. Proc Nat l Acad Sci USA 1998;95: 6642-6646.
30. Shapiro MJ, et al: Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin. J Biol Chem 2000;275:25216-25221.
31. Nakanishi-Matsui M, et al: PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000;404: 609-613.
32. Karnik SS, et al: Activation of G-protein-coupled receptors: a common molecular mechanism. Trends Endocrinol Metab 2003;14 : 431-437.
33. Gainetdinov RR, et al: Desensitization of G-protein-coupled receptors and neuronal functions. A nnu Rev Neurosci 2004;27: 1 0 7-144 .
34. Tilakaratne N, Sexton PM: G-Protein-coupled receptor-protein interactions: basis for new concepts on receptor structure and function. Clin Exp Pharmacol Physiol 2005;32:979-987.
35. Hoxie JA, et al: Internalization and recycling of activated thrombin receptors. J Biol Chem 19 93;268: 13756-13763.
36. Trejo J, Coughlin SR: The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling. J Biol Chem 1999;274:2216-2224.
37. Trejo J, Hammes SR, Coughlin SR: Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. Proc Natl Acad Sci USA 1998;95: 13698-13702.
38. Shapiro MJ, Coughlin SR: Separate signals for agonist-independent and agonist-triggered trafficking of protease-activated receptor 1. J Biol Chem 1998;273: 29009-29014.
39. Ludeman MJ, et al: Regulated shedding of PAR1 N-terminal exodomain from endothelia l cells. J Biol Chem 2004;279: 18 5 9 2-18599.
40. Tellez C, Bar-Eli M: Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene 2003;22: 31 3 0- 31 3 7.
41. Even-Ram S, et al: Thrombin receptor over-expression in malignant and physiological invasion processes. Nat Med 1998;4:909-914.
42. Cooper CR, et al: Stromal factors involved in prostate carcinoma metastasis to bone. Cancer 2003;97(3 suppl):739-747.
43. Chay CH, et al: A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines. Urology 2002;60: 76 0-765.
44. Yuan TC, Lin MF: Protease-activated receptor 1: a role in prostate cancer metastasis. Clin Prostate Cancer 2004;3:189-191.
45. Granovsky-Grisaru S, et al: The pattern of protease activated receptor 1 expression in endometrial carcinoma. Gynecol Oncol 2006;103:802-806.
46. Rudroff C, et al: Expression of the thrombin receptor PAR-1 correlates with tumour cell differentiation of pancreatic adenocarcino-ma in vitro. Clin Exp Metastasis 2002;19: 181-189.
47. Grisaru-Granovsky S, et al: Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int J Cancer 2005;113:372-378.
48. Ghio P, et al: Prognostic role of protease-ac-tivated receptors 1 and 4 in resected stage IB non-small-cell lung cancer. Clin Lung Cancer 2006;7:395-400.
49. Black PC, et al: Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1,-2, and-4) in prostate cancer. Prostate 2007;67: 74 3-756 .
50. Fujimoto D, et al: Expression of protease-activated receptor-2 in gastric cancer. J Surg Oncol 2006;93:139-144.
51. Shibata K, et al: Protease-activating-receptor-2 is frequently expressed in papillary ad-enocarcinoma of the gallbladder. Oncol Rep 2004;12:1013-1016.
52. Massi D, et al: Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. Hum Pathol 2005;36: 676-685.
53. Jahan I, et al: Role of protease activated receptor-2 in tumor advancement of ovarian cancers. Ann Oncol 2007;18: 1506-1512.
54. Jahan I, et al: Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers. Oncol Rep 2007;17:345-350.
55. Kaufmann R, et al: PAR-1- and PAR-3-type thrombin receptor expression in primary cultures of human renal cell carcinoma cells. Int J Oncol 2002;20:177-180.
56. Whitehead I, Kirk H, Kay R: Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor. Oncogene 1995;10:713-721.
57. Yin YJ, et al: Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to β-catenin stabilization. Cancer Res 2006;66:5224-5233.
58. DAndrea MR, et al: Differential expression of protease-activated receptors-1 and-2 in stromal fibroblasts of normal, benign, and malignant human tissues. Am J Pathol 2001;158: 2031-2041.
59. Boire A, et al: PAR1 is a matrix metallopro-tease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 2005;120:303-313.
60. Salah Z, et al: Protease-activated receptor-1 (hPar1), a survival factor eliciting tumor progression. Mol Cancer Res 2007;5: 229-240.
61. Nierodzik ML, et al: Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 1991;87: 229-236.
62. Hu L, et al: Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. Blood 2004;104:2746-2751.
63. Nierodzik ML, et al: Protease-activated receptor 1 is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 1998;92: 3694-3700.
64. Darmoul D, et al: Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation. Mol Cancer Res 2004;2: 514-522.
65. Darmoul D, et al: Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol 2003;162: 1503-1513.
66. Huang YQ, Li JJ, Karpatkin S: Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathway. J Biol Chem 2000;275:6462-6468.
67. Zain J, et al: Concentration-dependent dual effect of thrombin on impaired growth/ apoptosis or mitogenesis in tumor cells. Blood 2000;95: 3133-3138.
68. Ahmad R, et al: Thrombin induces apoptosis in human tumor cells. Int J Cancer 2000;87: 707-715.
69. Ahmad R, Menezes J, Ahmad A: Signaling mechanism in the induction of apoptosis by thrombin in human tumor cells. Blood 2000;96: 4001.
70. Borensztajn KS, et al: Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation. Exp Cell Res 2007;313: 2622-2633.
71. Flynn AN, Buret AG: Proteinase-activated receptor 1 and cell apoptosis. Apoptosis 2004;9: 729-737.
72. Turgeon VL, Milligan CE, Houenou LJ: Activation of the protease-activated thrombin receptor-1 induces motoneuron degeneration in the developing avian embryo. J Neuropathol Exp Neurol 1999;58:499-504.
73. Chin AC, et al: Proteinase-activated receptor 1 activation induces epithelial apoptosis and increases intestinal permeability. Proc Natl Acad Sci USA 2003;100: 11104-11109.
74. Grand RJ, Turnell AS, Grabham PW: Cellular consequences of thrombin-receptor activation. Biochem J 1996;313:353-368.
75. Suzuki T, et al: Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 2005;33: 231-247.
76. Chalmers CJ, et al: Thrombin inhibits Bim (Bcl-2-interacting mediator of cell death) expression and prevents serum-withdrawal-induced apoptosis via protease-activated receptor 1. Biochem J 2003;375: 99-109.
77. Gorbacheva LR, et al: Proteinase-activated type 1 receptors are involved in the mechanism of protection of rat hippocampal neurons from glutamate toxicity. Bull Exp Biol Med 2005;140: 285-288.
78. Gorbacheva LR, et al: Modulation of hippocampal neuron survival by thrombin and factor Xa. Biochemistry (Mosc) 2006;71: 1082-1089.
79. Vouret-Craviari V, et al: Synthetic α-thrombin receptor peptides activate G protein-coupled signaling pathways but are unable to induce mitogenesis. Mol Biol Cell 1992;3:95-102.
80. Vouret-Craviari V, et al: Differential activation of p44mapk (ERK1) by α-thrombin and thrombin-receptor peptide agonist. Biochem J 1993;289:209-214.
81. McLaughlin JN, et al: Functional selectivity of G-protein signaling by agonist peptides and thrombin for the protease-activated receptor-1. J Biol Chem 2005;280:25048-25059.
82. Riewald M, Ruf W: Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J Biol Chem 2005;280:19808-19814.
83. Berg KA, et al: Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 1998;54:94-104.
84. Robb S, et al: Agonist-specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. EMBO J 1994;13:1325-1330.
85. Rao HV, et al: Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons. J Neurochem 2007;101: 498-505.
86. Huang YQ, et al: Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost 2001;86:1094-1098.
87. Yin YJ, et al: Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness. Arterioscler Thromb Vasc Biol 2003;23:940-944.
88. Caunt M, et al: Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost 2003;1:2097-2102.
89. Sarker KP, et al: Inhibition of thrombin-induced vascular endothelial growth factor production in human neuroblastoma (NB-1) cells by argatroban. Pathophysiol Haemost Thromb 2005;34:41-47.
90. Zania P, et al: Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis. J Pharmacol Exp Ther 2006;318: 246-254.
91. Caruso R, et al: Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. Am J Pathol 2006;169:268-278.
92. Miyata S, et al: Trypsin stimulates integrin a5b1-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of protein-ase-activated receptor-2. J Biol Chem 2000;275: 4592-4598.
93. Yoshii M, et al: Mast cell tryptase stimulates DLD-1 carcinoma through prosta-glandin- and MAP kinase-dependent manners. J Pharmacol Sci 2005;98: 450-458.
94. Nishibori M, Mori S, Takahashi HK: Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediat-ed proliferation of colon cancer cell. J Pharmacol Sci 2005;97: 25-30.
95. Darmoul D, et al: Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer 2001;85: 772-779.
96. Jikuhara A, et al: MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2. Life Sci 2003;73: 2817-2829.
97. Iwaki K, et al: A small interfering RNA targeting proteinase-activated receptor-2 is effective in suppression of tumor growth in a Panc1 xenograft model. Int J Cancer 2008;12 2 :65 8- 6 6 3.
98. Uchima Y, Sawada T, Hirakawa K: Action of antiproteases on pancreatic cancer cells. JOP 2007;8(4 suppl):479-487.
99. Yada K, et al: Protease-activated receptor-2 regulates cell proliferation and enhances c yclooxygenase-2 mRNA expression in human pancreatic cancer cells. J Surg Oncol 2005;89: 79-85.
100. Shimamoto R, et al: A role for protease-ac-tivated receptor-2 in pancreatic cancer cell proliferation. Int J Oncol 2004;24: 14 0 1-140 6.
101. Ohta T, et al: Protease-activated receptor-2 expression and the role of trypsin in cell proliferation in human pancreatic cancers. Int J Oncol 2003;23: 61- 66.
102. Matej R, et al: Proteinase-activated receptor-2 expression in breast cancer and the role of trypsin on growth and metabolism of breast cancer cell line MDA MB-231. Physiol Res 2007;56: 475-484.
103. Sanchez-Hernandez PE, et al: Protease-ac-tivated receptor-2 in cervical cancer proliferation. Gynecol Oncol 2008;108:19-26.
104. Shi X, et al: Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2004;2: 395- 402.
105. Versteeg HH, et al: Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008;111:190-199.
106. Liu Y, Mueller BM: Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways. Biochem Bio-phys Res Commun 20 06;344: 1263-1270.
107. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22: 4673-4680.
108. Tusnady GE, Simon I: The HMMTOP transmembrane topology prediction server. Bioinformatics 2001;17:849-850.
109. Tusnady GE, Simon I: Topology of membrane proteins. J Chem Inf Comput Sci 2001;41:364-368.
110. Contreras-Moreira B, Bates PA: Domain fishing: a first step in protein comparative modeling. Bioinformatics 2002;18: 1141-114 2.
111. Bates PA, Sternberg MJ: Model building by comparison at CASP3: using exper t knowledge and computer automation. Proteins 1999;(suppl 3):47-54.
112. Bates PA, et al: Enhancement of protein modeling by human intervention in applying the automatic programs 3D-Jigsaw and 3D-PSSM. Proteins 2001;(suppl 5):39-46.